Evaluation of the GORE® Ascending Stent Graft

Enrolling by invitation · Not applicable

Conditions studied: Aortic Aneurysm, Thoracic, Pseudoaneurysm, Aortic Dissection, Aorta; Lesion

In brief

The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.

Key facts

Study ID
NCT05800743
Run by
W.L.Gore & Associates
People needed
370
Starts
2023-11-28
Expected to finish
2034-01-01
Last updated by the study team
2026-05-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.